Entries by a.macht

Toolbox for impact: consortium of life science clusters offers tools to increase efficiency

The subject of impact measurement is of crucial importance for cluster organizations as they continuously aim to enhance their support to their ecosystems with ever more innovative and efficient services. Therefore, the INNAXE’s consortium has recently developed a “Toolbox for Cluster Organisations” allowing them to easily benchmark their regions and monitor the impact of their activities towards their stakeholders.

BioBLU® Single-Use Bioreactors and BioFlo® 320 bioprocess controller – Single-Use Simplicity Under Control

Single-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.

Next European Biotechnology Guide Edition

The “17th European Biotechnology Science & Industry Guide 2027” – the handbook will present the strengths and core competencies of companies and institutions in the fields of Biotech, Biopharma, BioServices and BioManufacturing in Europe. Besides the printed version the guide will also be available as a digital version.

Encouraging signs in a tough year for European biotech

Continuing geopolitical uncertainty has perpetuated volatility in global markets, exacerbated by higher inflation and interest rates. The impact has left the biotech market in a limbo as investors eschew riskier investments, but there are signs of a potential recovery ahead.